FDA and CMS Seek State Coordination on AI Health-Tech Regulation
The FDA and CMS are exploring greater collaboration with states on how artificial intelligence should be regulated in health technology. The reported initiative points toward a more coordinated oversight framework as AI increasingly plays a role in healthcare products and services.
Specific regulatory proposals and participating states were not detailed in the available report.